Seysara and Dexamethasone sodium phosphate drug interactions - a phase IV clinical study of FDA data
Summary:
We study 12,252 people who take Seysara (sarecycline hydrochloride) and Dexamethasone sodium phosphate (dexamethasone sodium phosphate). There is no drug interaction reported.
The study analyzes what interactions people have when they take Seysara and Dexamethasone sodium phosphate. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Seysara?
Seysara has active ingredients of sarecycline hydrochloride. eHealthMe is studying from 151 Seysara users. Check the latest studies of Seysara.
What is Dexamethasone sodium phosphate?
Dexamethasone sodium phosphate has active ingredients of dexamethasone sodium phosphate. It is often used in multiple myeloma. eHealthMe is studying from 12,101 Dexamethasone sodium phosphate users. Check the latest studies of Dexamethasone sodium phosphate.
No report is found.
Do you take Seysara and Dexamethasone sodium phosphate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Seysara (151 reports)
- Dexamethasone sodium phosphate (12,101 reports)
How the study uses the data?
The study uses data from the FDA. It is based on sarecycline hydrochloride and dexamethasone sodium phosphate (the active ingredients of Seysara and Dexamethasone sodium phosphate, respectively), and Seysara and Dexamethasone sodium phosphate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Meropenem cause Thrombocytopenia Neonatal? - now
- Could Adriamycin Pfs cause Gastric Polyps? - a second ago
- Drug interactions of Namenda and Flexeril - 4 seconds ago
- Could Metoprolol Succinate cause Jaw Disorder? - 5 seconds ago
- Could Xyrem cause Fluid Retention? - 8 seconds ago
- Could Atorvastatin Calcium cause Calcinosis? - 16 seconds ago
- Drug interactions of Soma and Vitamins - 22 seconds ago
- Could Coumadin cause Spinal Cord Disorder? - 23 seconds ago
- Elavil and Synthroid drug interactions for women aged 30-39 - 25 seconds ago
- Drug interactions of Diphen and Calcitriol - 30 seconds ago